• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名年轻女性保守治疗的子宫内膜复杂性非典型增生的进展:病例报告

Progression of conservatively treated endometrial complex atypical hyperplasia in a young woman: a case report.

作者信息

Corrado Giacomo, Baiocco Ermelinda, Carosi Mariantonia, Vizza Enrico

机构信息

Division of Gynecologic Oncology, National Cancer Institute Regina Elena, Rome, Italy.

出版信息

Fertil Steril. 2008 Nov;90(5):2006.e5-8. doi: 10.1016/j.fertnstert.2008.06.014. Epub 2008 Aug 9.

DOI:10.1016/j.fertnstert.2008.06.014
PMID:18692828
Abstract

OBJECTIVE

To describe a case of progression of endometrial complex atypical hyperplasia (CAH) to extrauterine endometrioid adenocarcinoma in a patient who had requested fertility-sparing management.

DESIGN

Case report.

SETTING

Division of Gynecologic Oncology, National Cancer Institute "Regina Elena," Rome, Italy.

PATIENT(S): A nulliparous 36-year-old woman with endometrial CAH who decided on a conservative approach.

INTERVENTION(S): Conservative hysteroscopic resection of the lesion, the surrounding endometrium, and underlying myometrium plus hormone therapy regimen of megestrol acetate (160 mg) daily for 6 months.

MAIN OUTCOME MEASURE(S): Failure of the conservative therapy and progression of disease.

RESULT(S): Eighteen months after fertility-sparing management, a laparoscopic operation revealed grade 2 endometrium adenocarcinoma with superficial myometrial invasion and a microscopic metastasis of the left ovary and Douglas peritoneum. The patient underwent adjuvant chemotherapy followed by external beam radiation of the pelvis and brachytherapy. Twenty-five months after, she was free of disease.

CONCLUSION(S): Conservative therapy is feasible in carefully selected young women with endometrial CAH. However, close follow-up is required because of possible progression to endometrial cancer.

摘要

目的

描述一例要求保留生育功能治疗的患者,其子宫内膜复杂性非典型增生(CAH)进展为子宫外子宫内膜样腺癌的病例。

设计

病例报告。

地点

意大利罗马国家癌症研究所“雷吉娜·埃琳娜”妇科肿瘤学部。

患者

一名36岁未生育的患有子宫内膜CAH的女性,决定采用保守治疗方法。

干预措施

通过宫腔镜对病变、周围子宫内膜及下方肌层进行保守性切除,外加醋酸甲地孕酮(160毫克)每日激素治疗方案,持续6个月。

主要观察指标

保守治疗失败及疾病进展。

结果

保留生育功能治疗18个月后,腹腔镜手术显示为2级子宫内膜腺癌,伴有浅肌层浸润以及左卵巢和Douglas腹膜的微小转移。患者接受了辅助化疗,随后进行盆腔外照射和近距离放疗。25个月后,她疾病无进展。

结论

对于精心挑选的患有子宫内膜CAH的年轻女性,保守治疗是可行的。然而,由于可能进展为子宫内膜癌,需要密切随访。

相似文献

1
Progression of conservatively treated endometrial complex atypical hyperplasia in a young woman: a case report.一名年轻女性保守治疗的子宫内膜复杂性非典型增生的进展:病例报告
Fertil Steril. 2008 Nov;90(5):2006.e5-8. doi: 10.1016/j.fertnstert.2008.06.014. Epub 2008 Aug 9.
2
Occult myometrial recurrence after progesterone therapy to preserve fertility in a young patient with endometrial cancer.孕激素治疗后隐匿性子宫肌层复发,用于一名年轻子宫内膜癌患者保留生育功能。
Fertil Steril. 2008 Mar;89(3):724.e1-3. doi: 10.1016/j.fertnstert.2007.03.068. Epub 2007 Jun 13.
3
[Outcome analysis of conservative treatment of well-differentiated endometrial adenocarcinoma and severe atypical hyperplasia in young women].[年轻女性高分化子宫内膜腺癌及重度非典型增生保守治疗的疗效分析]
Zhonghua Fu Chan Ke Za Zhi. 2006 Apr;41(4):242-5.
4
Development of metastatic endometrial endometrioid adenocarcinoma while on progestin therapy for endometrial hyperplasia.在接受孕激素治疗子宫内膜增生期间发生转移性子宫内膜样腺癌。
Gynecol Oncol. 2005 Nov;99(2):472-6. doi: 10.1016/j.ygyno.2005.06.050. Epub 2005 Aug 15.
5
Hysteroscopic Resection in Fertility-Sparing Surgery for Atypical Hyperplasia and Endometrial Cancer: Safety and Efficacy.保留生育功能手术治疗非典型增生和子宫内膜癌的宫腔镜切除术:安全性与有效性
J Minim Invasive Gynecol. 2015 Nov-Dec;22(7):1178-82. doi: 10.1016/j.jmig.2015.06.004. Epub 2015 Jun 16.
6
Prognostic impact of hysteroscopic resection of endometrial atypical hyperplasia-endometrioid intraepithelial neoplasia and early-stage cancer in combination with megestrol acetate.宫腔镜切除子宫内膜非典型增生-子宫内膜样上皮内瘤变及早期癌症联合甲地孕酮的预后影响
Am J Obstet Gynecol. 2021 Apr;224(4):408-410. doi: 10.1016/j.ajog.2020.12.1210. Epub 2020 Dec 30.
7
Fertility sparing treatment of complex atypical hyperplasia and low grade endometrial cancer using oral progestin.使用口服孕激素对复杂不典型增生和低级别子宫内膜癌进行保留生育力的治疗。
Gynecol Oncol. 2014 May;133(2):229-33. doi: 10.1016/j.ygyno.2014.02.020. Epub 2014 Feb 19.
8
Fertility-sparing treatment of endometrial cancer precursors among young women: a reproductive point of view.年轻女性子宫内膜癌前病变的保留生育力治疗:生殖观点。
Eur Rev Med Pharmacol Sci. 2012 Dec;16(14):1934-7.
9
Conservative surgical management of stage IA endometrial carcinoma for fertility preservation.保留生育力前提下的 IA 期子宫内膜癌的保守手术治疗。
Fertil Steril. 2010 Mar 1;93(4):1286-9. doi: 10.1016/j.fertnstert.2008.12.009. Epub 2009 Aug 22.
10
A prospective study of fertility-sparing treatment with megestrol acetate following hysteroscopic curettage for well-differentiated endometrioid carcinoma and atypical hyperplasia in young women.一项前瞻性研究显示,对于年轻女性的分化良好型子宫内膜样癌和非典型增生,在宫腔镜刮宫术后使用甲羟孕酮进行生育保留治疗。
Arch Gynecol Obstet. 2013 Nov;288(5):1115-23. doi: 10.1007/s00404-013-2826-8. Epub 2013 May 5.

引用本文的文献

1
Tracking the origin of simultaneous endometrial and ovarian cancer by next-generation sequencing - a case report.通过下一代测序追踪同时性子宫内膜癌和卵巢癌的起源——病例报告
BMC Cancer. 2017 Jan 19;17(1):66. doi: 10.1186/s12885-017-3054-6.